We are live on ! Find out more
KTC

Kistler-Tiffany Companies Portfolio holdings

AUM $616M
1-Year Est. Return 16.74%
This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+16.74%
3 Year Est. Return
+52%
5 Year Est. Return
+77.66%
10 Year Est. Return
+209.93%
AUM
$263M
AUM Growth
+$21.2M
Cap. Flow
+$14.5M
Cap. Flow %
5.51%
Top 10 Hldgs %
50.86%
Holding
604
New
28
Increased
145
Reduced
84
Closed
25

Top Sells

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$2.88M
2
EXC icon
Exelon
EXC
+$317K
3
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$313K
4
VZ icon
Verizon
VZ
+$279K
5
RTX icon
RTX Corp
RTX
+$272K

Sector Composition

Rank Sector Weight
1 Healthcare 9.99%
2 Technology 8.32%
3 Consumer Staples 4.58%
4 Communication Services 4.11%
5 Financials 3.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWD icon
51
iShares Russell 1000 Value ETF
IWD
$83.9B
$854K 0.32%
6,716
+225
+3% +$28.2K
PNC icon
52
PNC Financial Services
PNC
$102B
$837K 0.32%
6,094
VTV icon
53
Vanguard Morningstar Value ETF
VTV
$193B
$788K 0.3%
7,106
+2
+0% +$218
SBUX icon
54
Starbucks
SBUX
$123B
$772K 0.29%
9,205
-256
-3% -$20.1K
COST icon
55
Costco
COST
$421B
$766K 0.29%
2,898
+127
+5% +$31.7K
CSCO icon
56
Cisco
CSCO
$483B
$766K 0.29%
13,991
-1,039
-7% -$57.4K
UNH icon
57
UnitedHealth
UNH
$364B
$721K 0.27%
2,954
+632
+27% +$152K
VWO icon
58
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$688K 0.26%
16,168
+203
+1% +$8.54K
IBM icon
59
IBM
IBM
$221B
$682K 0.26%
5,171
CELG
60
DELISTED
Celgene Corp
CELG
$669K 0.25%
7,242
-1,746
-19% -$166K
GLD icon
61
SPDR Gold Trust
GLD
$144B
$664K 0.25%
4,987
-111
-2% -$13.7K
IBB icon
62
iShares Biotechnology ETF
IBB
$9.87B
$647K 0.25%
5,934
+10
+0.2% +$1.06K
PM icon
63
Philip Morris
PM
$290B
$642K 0.24%
8,170
-1,238
-13% -$102K
META icon
64
Meta Platforms (Facebook)
META
$1.48T
$637K 0.24%
3,303
C icon
65
Citigroup
C
$231B
$625K 0.24%
8,926
+38
+0.4% +$2.54K
HD icon
66
Home Depot
HD
$346B
$621K 0.24%
2,985
+115
+4% +$22.9K
ABBV icon
67
AbbVie
ABBV
$439B
$597K 0.23%
8,216
+459
+6% +$36.1K
MMM icon
68
3M
MMM
$94.8B
$593K 0.23%
4,092
IDV icon
69
iShares International Select Dividend ETF
IDV
$8.5B
$588K 0.22%
19,126
+535
+3% +$16.6K
RPG icon
70
Invesco S&P 500 Pure Growth ETF
RPG
$2.08B
$582K 0.22%
24,345
MA icon
71
Mastercard
MA
$488B
$533K 0.2%
2,016
+422
+26% +$106K
GOOG icon
72
Alphabet (Google) Class C
GOOG
$4.18T
$511K 0.19%
9,460
-20
-0.2% -$1.15K
IWO icon
73
iShares Russell 2000 Growth ETF
IWO
$15B
$511K 0.19%
2,546
+718
+39% +$142K
BMY icon
74
Bristol-Myers Squibb
BMY
$130B
$508K 0.19%
11,206
-845
-7% -$39.4K
MCD icon
75
McDonald's
MCD
$195B
$502K 0.19%
2,417
-551
-19% -$109K

Similar funds

Kistler-Tiffany Companies's Q2 2019 Portfolio in Review

As of Q2 2019, Kistler-Tiffany Companies held 604 positions worth $263M, up 8.8% from $242M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Kistler-Tiffany Companies deployed $14.5M of net new capital in Q2 2019, opening 28 new positions and adding to 145 existing holdings. Its largest new stake was Dow Inc: 6,430 shares worth $317K.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was West Pharmaceutical, an estimated $2.88M trimmed.

  • Kistler-Tiffany Companies's largest Q2 2019 buy was Dow Inc: 6,430 shares worth $317K.
  • Kistler-Tiffany Companies added most to Mesa Laboratories in Q2 2019, an estimated $6.54M increase.
  • Kistler-Tiffany Companies's biggest Q2 2019 reduction was West Pharmaceutical, cutting an estimated $2.88M.
  • Kistler-Tiffany Companies fully exited Blackstone in Q2 2019, selling an estimated $251K.
  • Kistler-Tiffany Companies's ten largest holdings make up 51% of its $263M portfolio in Q2 2019.
  • Kistler-Tiffany Companies opened 28 new positions and closed 25 in Q2 2019.
  • Kistler-Tiffany Companies's portfolio value rose 8.8% quarter-over-quarter to $263M.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2019, filed 22 Jul 2019.